Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and β-tricalcium phosphate

被引:263
作者
Takahashi, Y [1 ]
Yamamoto, M [1 ]
Tabata, Y [1 ]
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Dept Biomat,Sakyo Ku, Kyoto 6068507, Japan
关键词
mesenchymal stem cells; sponge scaffold; gelatin; beta-tricalcium phosphate; osteogenic differentiation;
D O I
10.1016/j.biomaterials.2004.09.046
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Biodegradable gelatin sponges incorporating various amounts of beta-tricalcium phosphate (betaTCP) (gelatin-betaTCP) were fabricated and the in vitro osteogenic differentiation of mesenchymal stem cells (MSC) isolated from the rat bone marrow in the sponges was investigated. The gelatin sponges incorporating betaTCP have an interconnected pore structure with the average size of 180-200 gm, irrespective of the betaTCP amount. The stiffness of the sponges became higher with an increase in the amount of betaTCP. When seeded into the sponges by an agitated method, MSC were homogeneously distributed throughout the sponge. The morphology of cells attached got more spreaded with the increased betaTCP amount. The rate of MSC proliferation depended on the betaTCP amount and culture method: the higher the betaTCP amount in the stirring culture, the higher the proliferation rate. The deformed extent of gelatin-betaTCP sponges was suppressed with the increased amount of betaTCP. When measured to evaluate the osteogenic differentiation of MSC, the alkaline phosphatase activity and osteocalcin content became maximum for the sponge with a betaTCP amount of 50 wt%, although both the values were significantly high in the stirring culture compared with those in the static culture. We concluded that the attachment, proliferation, and osteogenic differentiation of MSC were influenced by sponge composition of gelatin and betaTCP as the cell scaffold. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3587 / 3596
页数:10
相关论文
共 53 条
[21]  
2-P
[22]  
Kobayashi D, 1996, J BIOCHEM, V119, P475
[23]  
Kuijpers AJ, 2000, J BIOMED MATER RES, V51, P136, DOI 10.1002/(SICI)1097-4636(200007)51:1<136::AID-JBM18>3.0.CO
[24]  
2-W
[25]   TISSUE ENGINEERING [J].
LANGER, R ;
VACANTI, JP .
SCIENCE, 1993, 260 (5110) :920-926
[26]   Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration [J].
Laurencin, CT ;
Attawia, MA ;
Lu, LQ ;
Borden, MD ;
Lu, HH ;
Gorum, WJ ;
Lieberman, JR .
BIOMATERIALS, 2001, 22 (11) :1271-1277
[27]   A CHEMICALLY-DEFINED MEDIUM SUPPORTS IN-VITRO PROLIFERATION AND MAINTAINS THE OSTEOCHONDRAL POTENTIAL OF RAT MARROW-DERIVED MESENCHYMAL STEM-CELLS [J].
LENNON, DP ;
HAYNESWORTH, SE ;
YOUNG, RG ;
DENNIS, JE ;
CAPLAN, AI .
EXPERIMENTAL CELL RESEARCH, 1995, 219 (01) :211-222
[28]  
Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO
[29]  
2-7
[30]   Collagen-hydroxyapatite composite prepared by biomimetic process [J].
Lickorish, D ;
Ramshaw, JAM ;
Werkmeister, JA ;
Glattauer, V ;
Howlett, CR .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 68A (01) :19-27